Dexonal, 25 mg 10 pcs

Musculoskeletal pain (mild to moderately pronounced), algodysmenorrhea, toothache.

The drug is intended for symptomatic treatment, reducing pain and inflammation at the time of use.

Indications

Musculoskeletal pain (mild or moderate), algodismenorrhea, toothache.

The drug is intended for symptomatic treatment, reducing pain and inflammation at the time of use.

Pharmacological effect

Pharmacotherapeutic group:

Special instructions

Undesirable side effects can be minimized by using the drug in the lowest effective dose with the minimum duration of use necessary to relieve pain.

Active ingredient

Dexketoprofen

Composition

1 tablet contains:

Pregnancy

The use of Dexonal® during pregnancy and breastfeeding is contraindicated.

Contraindications

Hypersensitivity to dexketoprofen, other components of the drug and other NSAIDs;
complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and paranasal sinuses and intolerance to acetylsalicylic acid or other NSAIDs (including a history);
erosive and ulcerative lesions of the gastrointestinal tract in the acute stage;
history of gastrointestinal bleeding or perforation, including those associated with previous use of NSAIDs;
gastrointestinal bleeding; other active bleeding (including suspected intracranial hemorrhage);
inflammatory bowel diseases (Crohn’s disease, ulcerative colitis) in the acute stage;
severe liver failure (10-15 points on the Child-Pugh scale);
progressive kidney disease, confirmed hyperkalemia;
chronic kidney disease: stage 3 (glomerular filtration rate (GFR) 45-59 ml/min/1.73 m2), 36 (GFR 30-44 ml/min/1.73 m2) and 4 (GFR < 30 ml/min/1.73 m2); period after coronary artery bypass surgery; severe heart failure (III-IV class according to the NYHA classification); hemorrhagic diathesis and other blood clotting disorders; age under 18 years (due to lack of data on effectiveness and safety); pregnancy and breastfeeding period. With caution

Peptic ulcer of the stomach and duodenum, ulcerative colitis, Crohn’s disease, history of liver disease, hepatic porphyria. chronic kidney disease, stage 2 (GFR 60-89 ml/min/1.73 m2), chronic heart failure, arterial hypertension, significant decrease in circulating blood volume (including after surgery), elderly patients over 65 years of age (including those receiving diuretics, debilitated patients and patients with low body weight), bronchial asthma, simultaneous use of glucocorticosteroids (including including prednisolone), anticoagulants (including warfarin), antiplatelet agents (including acetylsalicylic acid, clopidogrel), selective serotonin reuptake inhibitors (including citalopram, fluoxetine, paroxetine, sertraline), coronary heart disease, cerebrovascular diseases, dyslipidemia/hyperlipidemia, diabetes mellitus, peripheral diseases arteries, smoking, Helicobacter pylori infection, systemic lupus erythematosus (SLE) and other systemic connective tissue diseases, long-term use of non-steroidal anti-inflammatory drugs, tuberculosis, severe osteoporosis, alcoholism, severe somatic diseases.

Side Effects

Possible side effects are listed in accordance with the World Health Organization classification below in descending order of occurrence: very often (≥1/10); often (≥1/100, <1/10); uncommon (≥ 1/1000, < 1/100); rare (≥1/10000, <1/1000); very rare (< 1/10000), including isolated reports.

Interaction

The following interactions are common to all NSAIDs.

Overdose

Symptoms: nausea, anorexia, abdominal pain, headache, dizziness, disorientation, insomnia.

Storage conditions

At a temperature not exceeding 25 °C.
Keep out of the reach of children.

Shelf life

3 years. Do not use the drug after the expiration date indicated on the package.

Manufacturer

Alium JSC, Russia